Overview To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions Status: Completed Trial end date: 2004-04-01 Target enrollment: Participant gender: Summary To demonstrate the relative bioavailability of Cefzil 500 mg Cefprozil tablets under fasting conditions. Phase: Phase 1 Details Lead Sponsor: SandozTreatments: CefprozilCephalosporins